Innodem Neurosciences: ETNA DEVICE FROM THE LEADING DIGITAL HEALTH & AI COMPANY INNODEM NEUROSCIENCES RECEIVES FDA BREAKTHROUGH DESIGNATION FOR MULTIPLE SCLEROSIS
MONTREAL, May 31, 2022 /PRNewswire/ -- Innodem Neurosciences, a leading provider of innovation and technology for the convergence of neurosciences, digital health, pharmaceutical and artificial
New York United States Prnewswire Innodem Neurosciences Marc Reeves Embs Gmbs Kostenloser Wertpapierhandel
Source: finanznachrichten.de